Guardant Health Director Alex M. Azar II Sells Shares Under Rule 10b5-1 Plan
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Insider Sale Alert: Guardant Health, Inc. ($GH) Insider: Alex M. Azar II (Director) Action: Sold 69 shares of Common Stock at $159.89 Total Value: $11,032.41 Shares Held After: 893 Plan: Rule 10b5-1 Pre-scheduled Plan
Comprehensive Analysis
Executive Summary
On October 14, 2026, Guardant Health, Inc. ($GH) director Alex M. Azar II executed a small open-market sale of 69 shares of Common Stock at a price of $159.89 per share, totaling approximately $11,032.41. The sale was made pursuant to a Rule 10b5-1 trading plan.
Transaction Details
- Reporting Owner: Alex M. Azar II
- Role: Director
- Security: Common Stock
- Transaction Code: S (Open-market sale)
- Shares Sold: 69 shares
- Execution Price: $159.89
- Gross Proceeds: $11,032.41
- Remaining Holdings: 893 shares directly owned
- Trading Plan: Executed under a pre-established Rule 10b5-1 plan
Significance & Market Context
The trading significance of this transaction is rated Low. The transaction volume is minimal, representing 69 shares and roughly $11k in gross proceeds. Furthermore, the sale was conducted under a Rule 10b5-1 trading arrangement, indicating pre-scheduled liquidation rather than discretionary market timing.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.